CASTELLUCCI, PAOLO
CASTELLUCCI, PAOLO
CASTELLUCCI P; P. CASTELLUCCI
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection
2024 Droghetti M.; Bianchi L.; Presutti M.; Vetrone L.; Farolfi A.; Mei R.; Giunchi F.; Degiovanni A.; Mottaran A.; Piazza P.; Cangemi D.; Castellucci P.; D'Errico A.; Schiavina R.; Brunocilla E.; Fanti S.
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial
2023 Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge
2023 Vetrone L.; Cuzzani G.; Mei R.; Zanoni L.; Bertaccini A.; Bianchi L.; Castellucci P.; Gaudiano C.; Cappelli A.; Giunchi F.; Fanti S.
Complete metabolic response after Partially Ablative Radiotherapy (PAR) for bulky retroperitoneal liposarcoma: A case report
2023 Medici, Federica; Strolin, Silvia; Castellucci, Paolo; Cilla, Savino; Laghi, Viola; Galietta, Erika; Vadalà, Maria; Strigari, Lidia; Morganti, Alessio Giuseppe; Cammelli, Silvia
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax
2023 Gottardi, Francesca; Baccelli, Francesco; Leardini, Davide; Di Battista, Antonia; Castellucci, Paolo; D'Amico, Domenico; Serravalle, Salvatore; Bertuccio, Salvatore Nicola; Messelodi, Daria; Prete, Arcangelo; Masetti, Riccardo
A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae
2022 Telo, Silvi; Farolfi, Andrea; Castellucci, Paolo; Antonacci, Filippo; Solli, Piergiorgio; Mosconi, Cristina; Fanti, Stefano; Agosti, Roberto; Morigi, Joshua James; Nanni, Cristina
CARE-compliant stereotactic radiotherapy of urothelial nodal metastases: A case report
2022 Medici, Federica; Siepe, Giambattista; Strigari, Lidia; Massari, Francesco; Buwenge, Milly; Bisello, Silvia; Castellucci, Paolo; Fanti, Stefano; Cammelli, Silvia; Morganti, Alessio Giuseppe
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study
2022 Mattoni, Susanna; Farolfi, Andrea; Formaggio, Fabio; Bruno, Gabriel; Caroli, Paola; Cerci, Juliano Julio; Eiber, Matthias; Fendler, Wolfgang Peter; Golfieri, Rita; Herrmann, Ken; Matteucci, Federica; Mosconi, Cristina; Paolani, Giulia; Santoro, Miriam; Strigari, Lidia; Nanni, Cristina; Castellucci, Paolo; Fanti, Stefano
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer.
2021 Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S, Castellucci P.
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series.
2021 Francolini G, Detti B, Bottero M, Zilli T, Lancia A, Bruni A, Borghesi S, Mariotti M, Castellucci P, Fanti S, Filippi AR, Teriaca MA, Maragna V, Aristei C, Mazzeo E, Livi L, Ingrosso G.
High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results.
2021 Castellucci P, Savoia F, Farina A, Lima GM, Patrizi A, Baraldi C, Zagni F, Vichi S, Pettinato C, Morganti AG, Strigari L, Fanti S.
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study.
2021 Farolfi A, Hirmas N, Gafita A, Weber M, Barbato F, Wetter A, Mei R, Pianori D, Hadaschik B, Herrmann K, Castellucci P, Fanti S, Eiber M, Fendler WP.
Incidental finding of [68Ga]Ga-PSMA-avid intraductal papillary mucinous neoplasm
2021 Calabrò D, Zanoni L, Mosconi C, Farolfi A, Golfieri R, Matteucci F, Caroli P, Fanti S, Castellucci P
Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series.
2021 Farolfi A, Telo S, Castellucci P, Morais de Campos AL, Rosado-de-Castro PH, Altino de Almeida S, Artigas C, Scarlattei M, Leal A, Deandreis D, Fanti S, Fendler WP, Mosconi C, Pianori D, Ruffini L, Ceci F.
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget.
2021 Mei R, Farolfi A, Castellucci P, Nanni C, Zanoni L, Fanti S.
Alternative and New Radiopharmaceutical Agents for Lung Cancer.
2020 Telo S, Calderoni L, Vichi S, Zagni F, Castellucci P, Fanti S.
Evaluation of an Automated Module Synthesis and a Sterile Cold Kit-Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer.
2020 Calderoni L, Farolfi A, Pianori D, Maietti E, Cabitza V, Lambertini A, Ricci G, Telo S, Lodi F, Castellucci P, Fanti S.
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL.
2020 Telo S, Fanti S, Nanni C, Lambertini A, Picchio M, Gianolli L, Schiavina R, Bianchi L, Briganti A, Mapelli P, Castellucci P, Farolfi A.
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer
2020 Ceci F, Bianchi L, Borghesi M, Polverari G, Farolfi A, Briganti A, Schiavina R, Brunocilla E, Castellucci P, Fanti S
Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database
2020 Bianchi L.; Borghesi M.; Schiavina R.; Castellucci P.; Ercolino A.; Bianchi F.M.; Barbaresi U.; Polverari G.; Brunocilla E.; Fanti S.; Ceci F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection | Droghetti M.; Bianchi L.; Presutti M.; Vetrone L.; Farolfi A.; Mei R.; Giunchi F.; Degiovanni A.;... Mottaran A.; Piazza P.; Cangemi D.; Castellucci P.; D'Errico A.; Schiavina R.; Brunocilla E.; Fanti S. | 2024-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Droghetti_2024.pdf |
| Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial | Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; ...Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G | 2023-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | Guido A et al, 2023.pdf |
| Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge | Vetrone L.; Cuzzani G.; Mei R.; Zanoni L.; Bertaccini A.; Bianchi L.; Castellucci P.; Gaudiano C....; Cappelli A.; Giunchi F.; Fanti S. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-13-1101221.pdf |
| Complete metabolic response after Partially Ablative Radiotherapy (PAR) for bulky retroperitoneal liposarcoma: A case report | Medici, Federica; Strolin, Silvia; Castellucci, Paolo; Cilla, Savino; Laghi, Viola; Galietta, Eri...ka; Vadalà, Maria; Strigari, Lidia; Morganti, Alessio Giuseppe; Cammelli, Silvia | 2023-01-01 | RADIOLOGY CASE REPORTS | - | 1.01 Articolo in rivista | Medici et al, Partially ablative RT for bulky retroperitoneal Liposarcoma, Radiol Case Report 2023.pdf |
| Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax | Gottardi, Francesca; Baccelli, Francesco; Leardini, Davide; Di Battista, Antonia; Castellucci, Pa...olo; D'Amico, Domenico; Serravalle, Salvatore; Bertuccio, Salvatore Nicola; Messelodi, Daria; Prete, Arcangelo; Masetti, Riccardo | 2023-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae | Telo, Silvi; Farolfi, Andrea; Castellucci, Paolo; Antonacci, Filippo; Solli, Piergiorgio; Mosconi..., Cristina; Fanti, Stefano; Agosti, Roberto; Morigi, Joshua James; Nanni, Cristina | 2022-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| CARE-compliant stereotactic radiotherapy of urothelial nodal metastases: A case report | Medici, Federica; Siepe, Giambattista; Strigari, Lidia; Massari, Francesco; Buwenge, Milly; Bisel...lo, Silvia; Castellucci, Paolo; Fanti, Stefano; Cammelli, Silvia; Morganti, Alessio Giuseppe | 2022-01-01 | MOLECULAR AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | mco-16-04-02518.pdf |
| PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study | Mattoni, Susanna; Farolfi, Andrea; Formaggio, Fabio; Bruno, Gabriel; Caroli, Paola; Cerci, Julian...o Julio; Eiber, Matthias; Fendler, Wolfgang Peter; Golfieri, Rita; Herrmann, Ken; Matteucci, Federica; Mosconi, Cristina; Paolani, Giulia; Santoro, Miriam; Strigari, Lidia; Nanni, Cristina; Castellucci, Paolo; Fanti, Stefano | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-05680-v2.pdf; cancers-14-05680-s001.zip |
| Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer. | Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S, Castellucci P. | 2021-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series. | Francolini G, Detti B, Bottero M, Zilli T, Lancia A, Bruni A, Borghesi S, Mariotti M, Castellucci... P, Fanti S, Filippi AR, Teriaca MA, Maragna V, Aristei C, Mazzeo E, Livi L, Ingrosso G. | 2021-01-01 | CLINICAL & TRANSLATIONAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results. | Castellucci P, Savoia F, Farina A, Lima GM, Patrizi A, Baraldi C, Zagni F, Vichi S, Pettinato C, ...Morganti AG, Strigari L, Fanti S. | 2021-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | s00259-020-05088-z.pdf |
| Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study. | Farolfi A, Hirmas N, Gafita A, Weber M, Barbato F, Wetter A, Mei R, Pianori D, Hadaschik B, Herrm...ann K, Castellucci P, Fanti S, Eiber M, Fendler WP. | 2021-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Incidental finding of [68Ga]Ga-PSMA-avid intraductal papillary mucinous neoplasm | Calabrò D, Zanoni L, Mosconi C, Farolfi A, Golfieri R, Matteucci F, Caroli P, Fanti S, Castellucci P | 2021-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series. | Farolfi A, Telo S, Castellucci P, Morais de Campos AL, Rosado-de-Castro PH, Altino de Almeida S, ...Artigas C, Scarlattei M, Leal A, Deandreis D, Fanti S, Fendler WP, Mosconi C, Pianori D, Ruffini L, Ceci F. | 2021-01-01 | AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget. | Mei R, Farolfi A, Castellucci P, Nanni C, Zanoni L, Fanti S. | 2021-01-01 | SEMINARS IN NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Alternative and New Radiopharmaceutical Agents for Lung Cancer. | Telo S, Calderoni L, Vichi S, Zagni F, Castellucci P, Fanti S. | 2020-01-01 | CURRENT RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| Evaluation of an Automated Module Synthesis and a Sterile Cold Kit-Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer. | Calderoni L, Farolfi A, Pianori D, Maietti E, Cabitza V, Lambertini A, Ricci G, Telo S, Lodi F, C...astellucci P, Fanti S. | 2020-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | AM_jnumed.119.231605.full.pdf |
| Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL. | Telo S, Fanti S, Nanni C, Lambertini A, Picchio M, Gianolli L, Schiavina R, Bianchi L, Briganti A..., Mapelli P, Castellucci P, Farolfi A. | 2020-01-01 | NUCLEAR MEDICINE COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
| Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer | Ceci F, Bianchi L, Borghesi M, Polverari G, Farolfi A, Briganti A, Schiavina R, Brunocilla E, Cas...tellucci P, Fanti S | 2020-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | Ceci_Bianchi_predicition.pdf |
| Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database | Bianchi L.; Borghesi M.; Schiavina R.; Castellucci P.; Ercolino A.; Bianchi F.M.; Barbaresi U.; P...olverari G.; Brunocilla E.; Fanti S.; Ceci F. | 2020-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |